Case Report

You have full text access to this OnlineOpen article

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma

  1. Takuya Matsunaga1,*,
  2. Kazuyuki Murase1,
  3. Makoto Yoshida1,
  4. Akihito Fujimi1,
  5. Satoshi Iyama1,
  6. Kageaki Kuribayashi1,
  7. Tsutomu Sato1,
  8. Katsuhisa Kogawa2,
  9. Yasuo Hirayama3,
  10. Sumio Sakamaki3,
  11. Kyuhei Kohda4,
  12. Yoshiro Niitsu1

Article first published online: 25 JUL 2005

DOI: 10.1002/ajh.20349

Issue

American Journal of Hematology

American Journal of Hematology

Volume 79, Issue 4, pages 294–298, August 2005

Additional Information

How to Cite

Matsunaga, T., Murase, K., Yoshida, M., Fujimi, A., Iyama, S., Kuribayashi, K., Sato, T., Kogawa, K., Hirayama, Y., Sakamaki, S., Kohda, K. and Niitsu, Y. (2005), Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am. J. Hematol., 79: 294–298. doi: 10.1002/ajh.20349

Author Information

  1. 1

    Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine, Japan

  2. 2

    Department of Internal Medicine, Tokeidai Hospital, Japan

  3. 3

    Department of Internal Medicine, Higashi Sapporo Hospital, Japan

  4. 4

    Department of Internal Medicine, Asahikawa Red Cross Hospital, Japan

*4th Department of Internal Medicine, Sapporo Medical University, South-1 West-17, Chuo-ku, Sapporo, Japan

Publication History

  1. Issue published online: 25 JUL 2005
  2. Article first published online: 25 JUL 2005
  3. Manuscript Accepted: 30 NOV 2004
  4. Manuscript Received: 6 SEP 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (233K)

REFERENCES

  • 1
    Powles R, Mehta J, Kulkarni S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000;355:1231–1237.
  • 2
    Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815–1822.
  • 3
    Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994;84:3603–3612.
  • 4
    Niederwieser DW, Appelbaum FR, Gastl G, et al. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 1990;322:1794–1796.
  • 5
    Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784–789.
  • 6
    Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 2000;63:46–53.
    Direct Link:
  • 7
    Hambach L, Eder M, Dammann E, et al. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 2001;28:705–707.
  • 8
    Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 2002;29:999–1003.
  • 9
    Lawler M, Locasciulli A, Longoni D, Schiro R, McCann SR. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Bone Marrow Transplant 2002;29(5):453–456 [erratum: 2002;29(9):805].
  • 10
    Takahashi R, Shimazaki C, Inaba T, Nakagawa M, Yamaoka M. Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia. Jpn J Clin Hematol 2002;43:963–965.
  • 11
    Bielorai B, Deeg HJ, Weintraub M, et al. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant 2003;31:931–934.
  • 12
    Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001;113:375–382.
    Direct Link:
  • 13
    Mitelan F (editor). ISCN 1995. International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 1995.
  • 14
    Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet 1995;56:1125–1131.
  • 15
    Kikuchi A, Ohata Y, Matsumoto H, Sugiura M, Nishikawa T. Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma. Cancer 1997;79:269–274.
    Direct Link:
  • 16
    Yamamoto S, Hattori T, Matsuoka M, et al. Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cells. Blood 1986;67:1714–1720.
  • 17
    Imamura N, Inada T, Muramoto A. Multiple primary malignant neoplasms in patients with adult T-cell leukaemia. Lancet 1989;1:219.
Get PDF (233K)